Featured Research

from universities, journals, and other organizations

Uncovering a flaw in drug testing for chronic anxiety disorder

Date:

December 13, 2012

Source:

American Friends of Tel Aviv University

Summary:

Trials for experimental drugs are often done on laboratory mice because of their genetic similarity to humans. But now a study has found that, when it comes to chronic neurological disorders, researchers may be using the wrong kind of mouse.

Share This

Pre-clinical trials -- the stage at which medications or therapies are tested on animals like laboratory mice -- is a crucial part of drug development. It's only then that scientists can assess benefits and side effects before a drug is administered to patients.

Related Articles

Now, Prof. Ilan Golani of Tel Aviv University's Department of Zoology and Sagol School for Neuroscience and his fellow researchers Prof. Yoav Benjamini of TAU's Department of Statistics and Operations Research and the Sagol School of Neuroscience, and Dr. Ehud Fonio of the Weizmann Institute are questioning the animal models used for measuring chronic disorders such as Generalized Anxiety Disorder. Using a hundred-times longer experimental time-frame and comparing lab mice with wild mice, the researchers found that the lab mice used do not actually experience chronic anxiety.

Instead, the researchers found that the behavior exhibited by the mice in the first minutes of an experiment is only a temporary response to a new environment. With time, the mice revert back to their true temperaments -- lab mice have calm temperaments and wild mice are anxious. This discovery, which has been reported in the journals PLoS One and Nature Methods, could explain why most candidate drugs developed using this mouse model have poor therapeutic value in treating human brain disorders, says Prof. Golani.

Back to the wild

Because of their genetic similarity to humans, mice are the most commonly used lab animals. Countless hours and billions of dollars have been spent developing mouse models, whose genes can be engineered to mimic human diseases and disorders. And while many of these models have made invaluable contributions to the advancement of research into Parkinson's disease and various cancers, others have proven less effective.

A chronically anxious mouse model is crucial to test anti-anxiety therapies, says Prof. Golani. Currently, scientists use a specific strain of lab mice thought to be particularly anxious. During experiments, the mice are placed in a novel environment and monitored for signs of anxiety such as staying in sheltered rather than exposed space, for example. After drugs are administered, the mice are observed for a reduction in anxious behaviors.

The researchers compared the lab mouse strain now used for Generalized Anxiety Disorder testing to a strain of first-generation wild mice born in captivity. The time-frame of the experiment was extended from a few minutes to as long as 45 hours. Though the lab mice appeared more anxious at first, the scientists discovered that the lab mice eventually settle into calm behavior, while the wild mice exhibit consistently more anxious behavior: "In nature, mice must always be on high alert or they will get preyed upon," explains Prof. Golani.

They believe that the current Generalized Anxiety Disorder methodology for animal models should be revised because of three main experimental fallacies: use of the wrong animal, too short a time-frame, and analysis made at the wrong points in the experiment. These prevent the diagnosis of true chronic mal-behavior, they say.

Replicating results

In their Nature Methods article, the researchers call for similar scrutiny of other behavioral animal models. One important criterion is that findings from experiments conducted using an animal model must be replicable in other labs. The lack of replicability is a problem in the field, they note, which is currently insufficiently addressed by complicated and costly efforts to standardize experimental protocols.

Not every experiment needs to be replicated in many labs, sacrificing more animals, time and money, says Prof. Benjamini. "Developing a collaborative database that draws on the different experiments conducted across the globe, as well as using appropriate data mining tools, can yield the needed yardstick to check for replicability of findings for scientists in isolated labs," he adds. Such a community-based effort can help researchers better identify valid experimental results.

The Israeli Science Foundation and a European Research Council Grant supported the research.

More From ScienceDaily

More Mind & Brain News

Featured Research

Mar. 2, 2015 — A newly published study is the first to report an association between bisphenol-A (BPA), a common plasticizer used in a variety of consumer food and beverage containers, with autism spectrum disorder ... full story

Mar. 2, 2015 — On Feb. 26, a picture of a cocktail dress originally uploaded to the blog Tumblr swept the Internet and managed to divide the population over a simple question: What color is the dress? Some viewers ... full story

Mar. 2, 2015 — A deficiency in the protein responsible for moving glucose across the brain's protective blood-brain barrier appears to intensify the neurodegenerative effects of Alzheimer's disease, according to a ... full story

Mar. 2, 2015 — Researchers describe how postmortem brain slices can be 'read' to determine how a rat was trained to behave in response to specific sounds, a new article suggests. The work provides one of the first ... full story

Mar. 2, 2015 — Teenagers in North Carolina were easily able to buy electronic cigarettes online because both Internet vendors and shipping companies failed to verifying ages in a study that assessed compliance with ... full story

Mar. 2, 2015 — A survey of US high school students suggests that 1 in 5 female students and 1 in 10 male students who date have experienced some form of teen dating violence (TDV) during the past 12 months. "These ... full story

Mar. 2, 2015 — Cerebral blood flow recovery in the brain could be a biomarker of outcomes in patients following concussion, a new imaging study suggests. Most of the 3.8 million sports-related traumatic brain ... full story

Mar. 2, 2015 — Many patients undergoing chemotherapy experience severe taste disruptions that make eating a challenge at a time when maintaining good nutrition is extremely important. Now, researchers report that ... full story

Mar. 2, 2015 — Neuroscientists generally think of the front end of the human visual system as a simple light detection system: The patterns produced when light falls on the retina are relayed to the visual cortex ... full story

Mar. 2, 2015 — Navigational brain cells that help sense direction are as electrically active during deep sleep as they are during wake time, scientists have discovered. Such information could be useful in treating ... full story

Related Stories

Dec. 1, 2014 — Replenishing the supply of a molecule that normally activates cannabinoid receptors in the brain could relieve mood and anxiety disorders and enable some people to quit using marijuana, a new study ... full story

Aug. 30, 2012 — Researchers have identified a potential medical treatment for the cognitive effects of stress-related disorders, including post-traumatic stress disorder (PTSD). The study, conducted in a PTSD mouse ... full story

Aug. 1, 2011 — Self-medicating with alcohol or other drugs appears to be associated with an increased risk of substance use disorders and social phobia in patients with anxiety-related symptoms, according to a new ... full story

ScienceDaily features breaking news and videos about the latest discoveries in health, technology, the environment, and more -- from major news services and leading universities, scientific journals, and research organizations.